
NextGen: Liquid Immunizer To Equity Risk (NASDAQ:NXGN)
Solskin Investment summary As we’ve repeated many times to our audience here on Seeking Alpha, when it comes to the remainder of FY22, balanced portfolios with an allocation to alternatives are still an inexpensive defender […]